Selank
🔹 What is Selank?
Class: Synthetic heptapeptide (sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, MW 751.89 g/mol); analog of the naturally occurring immunomodulatory peptide tuftsin. Selank was previously designated TP-7, and was built by combining the tuftsin sequence with a stabilizing sequence to improve its durability against enzymatic breakdown. Notably, it shares the core Pro-Gly-Pro motif with Semax, which is part of why the two are sometimes alternated in protocols. Mechanism:
- Modulates GABAergic system → enhances inhibitory neurotransmission for anxiolytic effects.
- Increases serotonin and dopamine metabolism, balancing mood and motivation.
- Boosts BDNF expression, supporting synaptic plasticity and cognitive resilience, including elevating BDNF specifically in the hippocampus.
- Immunomodulatory: enhances T-helper cell balance and anti-inflammatory cytokine regulation, modulates interleukin-6, and regulates BCL6, a key immune-system transcriptional regulator.
- Reduces the breakdown of enkephalins, contributing to its calming/analgesic-adjacent profile.
- Non-sedating anxiolytic → unlike benzodiazepines, reduces anxiety without motor impairment or dependence.
- Metabolic/weight-related effects: prevents weight gain, decreases blood glucose, and works as an anticoagulant/fibrinolytic/antiplatelet agent — relevant to metabolic syndrome contexts.
Primary focus:
- Anxiety reduction (social/generalized).
- Mood stabilization (depression, stress resilience).
- Cognitive support (focus, learning, memory).
- Immune system modulation (anti-inflammatory, stress-related immune suppression).
🔹 Oral Dosage
- Poor oral bioavailability.
- Some experimental sublingual or lozenge forms exist: anecdotal range 250–1000 µg daily, but nasal/injectable routes are preferred.
🔹 Injectable / Nasal Dosage (most common) Range:
- 250–1000 µg per dose.
- Frequency: 1–3x daily, depending on stress/anxiety level.
Typical research protocols:
- 500 µg intranasal, 2x/day for 2–4 weeks.
- SC injections are less common but used at similar dose ranges.
Rationale: Intranasal delivery allows direct nose-to-brain uptake, bypassing systemic degradation.
Real-world compounded example: Selank 7,500 mcg/ml (6 ml nasal spray bottle) — dosed at 1–2 sprays intranasally daily or as needed, for neurological function and anxiety support.
🔹 Cycle Length
- Common cycles: 2–4 weeks for acute stress or anxiety.
- Long-term wellness use: 8–12 weeks, with breaks to avoid receptor desensitization.
🔹 Optimal Dosing Window
- Morning and/or midday → supports daytime mood stability and focus.
- Can be used in the evening if anxiety-related insomnia is an issue.
- Avoid overdosing late at night in sensitive individuals (may paradoxically cause alertness).
✅ Educational Integration Example Example protocol: 500 µg intranasal, twice daily (morning + early afternoon) for 6 weeks. Paired with: Omega-3 fatty acids + magnesium glycinate + good sleep hygiene. Rationale: Reinforces neurochemical balance while reducing stress-induced cognitive drain.
🔹 Stacking Strategy (Educational / Complementary) Since Selank primarily targets anxiety, mood, and cognitive stability, stacks should emphasize synergy with neurotrophic, metabolic, and nootropic pathways: 🔸 Mood & Anxiety Balance
- Semax → enhances BDNF and cognition, complements Selank’s anxiolysis.
- Lion’s Mane → supports NGF and long-term neuronal resilience.
- Ashwagandha or Rhodiola → adaptogenic balance for chronic stress.
🔸 Cognitive Enhancement
- Noopept → memory and learning enhancement, complements Selank’s stabilization.
- Dihexa → synaptogenesis and deep neuroplasticity.
- NAD⁺ / MOTS-c → mitochondrial support for cognitive stamina.
🔸 Immune & Anti-Inflammatory Synergy
- Thymosin Alpha-1 → broad immune regulation.
- KPV peptide → localized/systemic anti-inflammatory synergy.
Rationale: Selank acts as a stability anchor—reducing stress and balancing neurochemistry—so stacks pair best with plasticity enhancers, adaptogens, and mitochondrial support.
⚠️ Safety Notes
- Generally well tolerated; side effects are mild (fatigue, mild headache, nasal irritation).
- Non-addictive; no withdrawal syndrome like benzodiazepines.
- Data in healthy humans is limited; most research comes from Russia/Eastern Europe.
Studied in Humans? Yes
FDA Approved? No
Allowed for 503a Compounding Pharmacy? No
Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.